Desmond Tutu TB Centre Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02391415
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Desmond Tutu TB Centre | Desmond Tutu TB Centre (DTTC)

Active Ingredients

Drugs in Phase 2 Trials (2)

bacille calmette-guerin (1 trial)

dolutegravir (tivicay) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2